Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Item

http://www.wikidata.org/entity/Q34373536

Q34373536

about

Desensitization for solid organ and hematopoietic stem cell transplantation Modern approaches to incompatible kidney transplantation Treatment options and strategies for antibody mediated rejection after renal transplantation B cell repertoires in HLA-sensitized kidney transplant candidates undergoing desensitization therapy Incompatible live-donor kidney transplantation in the United States: results of a national survey Desensitization: Overcoming the Immunologic Barriers to Transplantation Therapeutic apheresis before and after kidney transplantation.The role of therapeutic apheresis in high immunologic risk renal transplantation: a review of current trends.Promising recent data on ABO incompatible liver transplantation: restrictions may apply.Intravenous immunoglobulin as clinical immune-modulating therapy.Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients.Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation.Diagnosis and management of antibody-mediated rejection: current status and novel approaches.IVIg treatment reduces catalytic antibody titers of renal transplanted patients Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic Opportunity Utility of HLA Antibody Testing in Kidney Transplantation.Intravenous immunoglobulin for antibody-mediated keratolimbal allograft rejection Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs.Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates A case of desensitization, transplantation, and allograft dysfunction.Humoral rejection of organ allografts.The patient: Emerging clinical applications of intravenous immunoglobulin.Transplantation across previously incompatible immunological barriers.Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients.Pediatric renal transplantation in a highly sensitised child-8 years on.Desensitization strategies enabling successful renal transplantation in highly sensitized patients.The HLA system: genetics, immunology, clinical testing, and clinical implications.New treatments for acute humoral rejection of kidney allografts.Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.Successful renal transplantation with desensitization in highly sensitized patients: a single center experience.Early and Sustained Reduction in Donor-Specific Antibodies in Desensitized Living Donor Kidney Transplant Recipients: A 3-Year Prospective Study.The role of positive flow cytometry crossmatch in late renal allograft loss Challenges with sensitized recipients in pediatric heart transplantation.Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine.Advances in diagnosing and managing antibody-mediated rejection.Antibody-Mediated Rejection: A Review.

P2860

Q26863564-85495F98-95CD-4617-AEE3-3EBC9AD3C715 Q27010224-E5BDEA9B-3FC2-4D0C-B05B-DE0620B7B665 Q27021397-BFEDEA31-D49D-4E94-AC6D-F0446171E7CB Q28563989-C5EA0BC1-1A07-4254-B47A-F5F0F4495C55 Q28741418-73F59C7A-F5D9-46B3-8366-B64560177CDE Q30397952-631FBC55-56EC-4D2E-8073-93948EC83FC6 Q30454250-395429D8-CFF1-431B-870B-F92F722072EB Q30455087-B9B20050-F2BC-44CF-8491-CF7BE8B7BBC4 Q31117692-F29705ED-6BD1-4E1C-A6C5-3EE303CDE0AB Q33420267-CE085441-D522-4F61-8E36-E9E785E510E0 Q33560520-F8300B94-C5C1-4E97-BDCD-9A03D3C639E7 Q33842250-42A06802-7347-49E8-AA0F-7431C94CD90D Q34124202-65BB87A5-2556-4845-8B55-9F568380E7D0 Q34767262-AA9100BA-1E7D-43F0-ACEB-52C382CC0BB3 Q34841849-8622864A-6A70-4C10-B748-7DD3C343532D Q34962680-F106576F-814A-48C1-AA88-AC984E90FC91 Q35616055-F17431CB-E1E0-4C7D-8D70-20503E5399AC Q35692718-1219D118-F48A-4159-AFE5-D2F07EA732EF Q35790601-E0DFEAD7-A424-4758-B3DB-F386515F3217 Q35808401-D0B7F747-149F-40B3-9C52-965AC1586D52 Q35955607-685343B6-C13B-4B26-882C-1957D87AE1C4 Q36053023-3685231E-C10F-4028-B42B-9DF03D5EBB3B Q36063312-E6C749AC-6D01-41BD-BE28-7A7DBA65C4CA Q36280431-AA9B9C53-398B-4529-9E32-B5BAF58761BE Q36288350-9155C4CB-D734-4581-995F-B52F2659127C Q36379447-A403F2F8-1473-408A-87C3-CBF7D263A5BA Q36392146-65A5910E-E62D-4E11-9483-F30FFF16750E Q36422175-2AA2A371-68D1-4672-A639-EF57E737D9EF Q36652013-0C018B91-0933-4846-A773-1F7B7E0A2938 Q36746594-AD4EC90C-518B-4E9F-B438-99AB7C6D8742 Q36802609-2023FE73-BB0F-4406-8F73-B4E7B8F8CD16 Q36827985-5FCF6215-E9FE-4BCA-8535-F4DE75F49C97 Q37078119-F8095097-092D-4FF9-8BC3-C7B3830702B1 Q37097768-5B9BF627-63D8-48A4-9605-E613FCE59635 Q37311402-6A322C32-9643-460C-92CF-9B0A7502652E Q37446864-A3A903E0-0658-4EEF-B213-EFD90786F17B Q37626123-F8836142-A64A-466E-9236-CB1891E6BEB5 Q37641415-32986FBF-0F04-4574-8C3A-82369F3928CF Q37676032-EF04A5B3-E971-4E11-88EC-2A7D67CAF31A Q37698860-A57ED1FE-1150-40D1-92C8-E4E4F89450AD

P2860

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Item

http://www.wikidata.org/entity/Q34373536

description

2004 nî lūn-bûn

@nan

2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu